Erythropoietin supports the survival of prostate cancer, but not growth and bone metastasis
Yusuke Shiozawa(Atrium Health Wake Forest Baptist), Russell S. Taichman(Tufts University)
Cited by 13
Related Papers
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633
The Role of CXCR7/RDC1 as a Chemokine Receptor for CXCL12/SDF-1 in Prostate Cancer
|Journal of Biological Chemistry|2007|454
Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis
|Nature Communications|2013|414
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia
|Nature Communications|2018|183
Erythropoietin Couples Hematopoiesis with Bone Formation
|PLoS ONE|2010|163